SrasV1, Main, Merge, indexHead, Idat.i

Index : Idat.i

Les termes de plus forte occurence

4	1058-4838:2003:Gorbach S:sars:bulletin:from
3	0019-5456:2003:Bhaskar G:severe:acute:respiratory
2	2243-4690:2019:Boullier H:inventing:prediction:for
2	1615-9853:2012:Li S:correlation:between:tgf
2	1590-4261:2008:Mo X:the:effects:of
2	1570-0232:2008:Bhatnagar P:sequential:affinity:purification
2	1521-6616:2006:Yang L:long:lived:effector
2	1521-6616:2004:Wang Y:detection:of:antibodies
2	1521-6616:2004:Wang Y:detecting:specific:cytotoxic
2	1473-3099:2005:Groneberg D:treatment:and:vaccines
2	1460-2725:2003:Groneberg D:severe:acute:respiratory
2	1424-6074:2006:Monceyron Jonassen C:sars:avian:coronaviruses
2	1424-6074:2005:Leiby D:emerging:infectious:agents
2	1424-6074:2004:Saif L:animal:coronavirus:vaccines
2	1386-6532:2009:Mahony J:multiplex:pcr:tests
2	1386-6532:2008:Sloots T:emerging:respiratory:agents
2	1386-6532:2008:Minosse C:phylogenetic:analysis:of
2	1386-6532:2008:Mackay I:human:rhinoviruses:the
2	1386-6532:2007:Lee N:co:circulation:of
2	1386-6532:2005:Zhou Y:the:design:and
2	1386-6532:2005:Savarino A:expanding:the:frontiers
2	1386-6532:2005:Niedrig M:first:external:quality
2	1386-6532:2004:Spiegel M:the:antiviral:effect
2	1386-6532:2004:Poon L:a:one:step
2	1386-6532:2004:Lee N:effects:of:early
2	1386-6532:2004:Chen F:in:vitro:susceptibility
2	1369-5274:2004:Ziebuhr J:molecular:biology:of
2	1368-5031:2005:Chen L:rhabdomyolysis:associated:with
2	1367-4803:2005:Shegogue D:object:oriented:biological
2	1367-4803:2005:Sachdeva G:spaan:a:software
2	1367-4803:2004:Sharma R:recognition:and:analysis
2	1359-6535:2007:Lin J:safety:and:immunogenicity
2	1359-6535:2007:Kuhn J:severe:acute:respiratory
2	1359-6535:2006:Amici C:indomethacin:has:a
2	1359-6535:2005:Zheng B:synthetic:peptides:outside
2	1359-6535:2004:Zheng B:prophylactic:and:therapeutic
2	1359-6535:2004:Scagnolari C:increased:sensitivity:of
2	1355-0284:2005:Wong S:the:severe:acute
2	1355-0284:2004:Navas Martin S:coronavirus:replication:and
2	1352-2310:2004:Agranovski I:monitoring:of:viable
2	1351-0711:2004:Wong O:severe:acute:respiratory
2	1286-4579:2011:Keng C:sars:coronavirus:b
2	1286-4579:2008:Mitsuki Y:a:single:amino
2	1286-4579:2007:Li G:lipid:rafts:play
2	1286-4579:2005:Yamate M:establishment:of:vero
2	1286-4579:2005:Leong W:microarray:and:real
2	1201-9712:2004:Keyaerts E:inhibition:of:sars
2	1198-743X:2004:Hsueh P:chronological:evolution:of
2	1092-2172:2008:Frieman M:mechanisms:of:severe
2	1092-2172:2005:Weiss S:coronavirus:pathogenesis:and
2	1072-4710:2004:Chang L:childhood:severe:acute
2	1061-4036:2006:Chan V:homozygous:l:sign
2	1058-4838:2010:Papenburg J:household:transmission:of
2	1058-4838:2006:Ohmit S:symptomatic:predictors:of
2	1058-4838:2006:Garbino J:a:prospective:hospital
2	1058-4838:2006:Chen W:nasopharyngeal:shedding:of
2	1058-4838:2005:Yu I:temporal:spatial:analysis
2	1058-4838:2005:Chiu S:human:coronavirus:nl
2	1058-4838:2004:Singh K:severe:acute:respiratory
2	1058-4838:2004:Dowell S:severe:acute:respiratory
2	1058-4838:2004:Christian M:severe:acute:respiratory
2	1058-4838:2004:Cheng V:viral:replication:in
2	1043-0342:2007:Kobinger G:human:immunodeficiency:viral
2	1018-8665:2006:Kariwa H:inactivation:of:sars
2	1017-7825:2008:Lee H:detection:of:antibodies
2	0981-9428:2005:Afreen F:spectral:quality:and
2	0969-7128:2005:Li T:sirna:targeting:the
2	0968-0896:2008:Shao Y:design:synthesis:and
2	0968-0896:2008:Mukherjee P:structure:based:virtual
2	0968-0896:2008:Cesarini S:thiocarbamates:as:non
2	0968-0896:2008:Akaji K:evaluation:of:peptide
2	0968-0896:2007:Ikejiri M:o:masked:deoxyadenosine
2	0968-0896:2005:Masuda N:studies:of:non
2	0968-0896:2001:Stephens C:synthesis:and:antiviral
2	0965-2140:2008:Hammett T:social:evils:and
2	0960-894X:2012:Yu M:identification:of:myricetin
2	0960-894X:2008:Ghosh A:design:synthesis:and
2	0960-894X:2007:Ikejiri M:synthesis:and:biological
2	0960-894X:2007:Ghosh A:structure:based:design
2	0960-894X:2006:Dooley A:from:genome:to
2	0960-894X:2005:Martina E:screening:of:electrophilic
2	0960-894X:2005:Chen L:synthesis:and:evaluation
2	0960-894X:2003:Jenwitheesuk E:identifying:inhibitors:of
2	0960-894X:2001:Johansson A:inhibition:of:hepatitis
2	0959-8138:2006:Zhong N:what:we:have
2	0959-8138:2003:Sheldon T:the:virus:hunter
2	0959-8138:2003:Parry J:sars:virus:identified
2	0959-8138:2003:Parry J:china:is:still
2	0959-8138:2003:Dyer O:two:strains:of
2	0956-5663:2009:Huang J:detection:of:severe
2	0956-5663:2008:Diaz Gonzalez M:dna:hybridization:biosensors
2	0956-4624:2007:Macconnachie A:three:men:a
2	0956-3202:2006:Chu C:antiviral:activity:of
2	0956-3202:2006:Barnard D:evaluation:of:immunomodulators
2	0956-3202:2005:Shigeta S:current:status:of
2	0956-3202:2005:Oxford J:new:antiviral:drugs
2	0956-3202:2005:Oxford J:a:throat:lozenge
2	0956-3202:2004:Barnard D:inhibition:of:severe
2	0956-3202:2003:Mcguigan C:halophenyl:furanopyrimidines:as
2	0954-6820:2006:Heeney J:zoonotic:viral:diseases
2	0951-418X:2008:Fiore C:antiviral:effects:of
2	0950-2688:2005:Lee C:seroprevalence:of:sars
2	0950-2688:2004:Yu I:the:epidemiology:of
2	0950-2688:2004:Teleman M:factors:associated:with
2	0950-2688:2004:Lau J:sars:preventive:and
2	0946-2716:2006:Kuba K:lessons:from:sars
2	0939-4451:2007:Wu G:prediction:of:mutations
2	0934-9723:2008:Lu C:sirna:silencing:of
2	0934-9723:2006:Lee N:role:of:laboratory
2	0934-9723:2005:Chen S:double:antigen:sandwich
2	0934-9723:2004:Tambyah P:sars:responding:to
2	0929-8673:2006:Wu Y:antiviral:drug:discovery
2	0929-8673:2005:Kesel A:synthesis:of:novel
2	0929-8673:2004:Takeda Shitaka M:protein:structure:prediction
2	0928-8244:2006:Mizutani T:inhibition:of:cell
2	0928-8244:2006:Lin C:severe:acute:respiratory
2	0924-8579:2010:Anderson L:update:on:sars
2	0918-2918:2005:Ishii H:virus:associated:hemophagocytic
2	0905-6157:2004:Van Bever H:childhood:severe:acute
2	0899-823X:2006:Tsai Y:airborne:severe:acute
2	0893-8512:2012:Cheng V:two:years:after
2	0891-3668:2008:Osterhaus A:new:respiratory:viruses
2	0891-3668:2007:Stockman L:severe:acute:respiratory
2	0891-3668:2005:Kahn J:history:and:recent
2	0891-3668:2004:Denison M:severe:acute:respiratory
2	0832-610X:2003:Peng P:infection:control:and
2	0815-9319:2005:Kwan A:severe:acute:respiratory
2	0767-0974:2003:Tratner I:sras:le:virus
2	0732-8893:2008:Lehmann C:a:line:immunoassay
2	0732-8893:2005:Chui L:comparison:of:different
2	0399-077X:2003:Guery B:syndrome:respiratoire:aigu
2	0378-8741:2008:Lau K:immunomodulatory:and:anti
2	0378-8741:2008:Chen C:toona:sinensis:roem
2	0378-1135:2008:Brockmeier S:coinfection:of:pigs
2	0360-1323:2011:Lim T:predictions:and:measurements
2	0342-4642:2004:Gomersall C:short:term:outcome
2	0309-2402:2004:Rassool G:current:issues:and
2	0305-7453:2008:Wong S:the:management:of
2	0305-7453:2006:Balzarini J:pyridine:n:oxide
2	0305-7453:2005:Yeh K:experience:of:using
2	0305-7453:2004:Oxford J:a:new:millennium
2	0304-8608:2012:Tsuda S:genomic:and:serological
2	0304-8608:2011:Hadjinicolaou A:development:of:a
2	0304-8608:2009:Obitsu S:potential:enhancement:of
2	0304-8608:2009:Chen J:interaction:between:sars
2	0304-8608:2007:Escutenaire S:sybr:green:real
2	0304-8608:2006:Bordi L:bcl:inhibits:the
2	0304-8608:2005:Hattermann K:susceptibility:of:different
2	0304-8608:2004:Gibbs A:the:phylogeny:of
2	0300-8126:2008:Lau J:perceptions:related:to
2	0277-9536:2006:Mak W:comparative:stigma:of
2	0277-9536:2005:Lee S:the:experience:of
2	0273-1223:2005:Wang X:concentration:and:detection
2	0272-6386:2003:Kwan B:severe:acute:respiratory
2	0271-3586:2006:Li Y:in:vivo:protective
2	0271-2091:2005:Lu W:a:preliminary:parametric
2	0270-9139:2004:Chau T:sars:associated:viral
2	0264-410X:2014:Coleman C:purified:coronavirus:spike
2	0264-410X:2011:Liu Y:chimeric:severe:acute
2	0264-410X:2009:Ohno S:synthetic:peptides:coupled
2	0264-410X:2008:Schulze K:a:prime:boost
2	0264-410X:2008:Mckinley E:avian:coronavirus:infectious
2	0264-410X:2008:Martin J:a:sars:dna
2	0264-410X:2008:Liniger M:induction:of:neutralising
2	0264-410X:2008:Kotwal G:genetic:diversity:independent
2	0264-410X:2007:Zakhartchouk A:immunogenicity:of:a
2	0264-410X:2007:Okada M:development:of:vaccines
2	0264-410X:2007:Kobinger G:adenovirus:based:vaccine
2	0264-410X:2007:Hu M:intranasal:protollin:formulated
2	0264-410X:2007:Cheung Y:induction:of:t
2	0264-410X:2006:Taylor D:obstacles:and:advances
2	0264-410X:2006:Roberts A:animal:models:and
2	0264-410X:2005:Zhang C:immune:responses:in
2	0264-410X:2005:Zakhartchouk A:augmentation:of:immune
2	0264-410X:2005:Woo P:sars:coronavirus:spike
2	0264-410X:2005:Wong J:prophylaxis:of:acute
2	0264-410X:2005:Wilde H:rabies:control:in
2	0264-410X:2005:Okada M:the:development:of
2	0264-410X:2005:Macdonald A:rov:asp:a
2	0264-410X:2005:Czub M:evaluation:of:modified
2	0264-410X:2003:De Groot A:how:the:sars
2	0253-9624:2020:Tian H:ncov:new:challenges
2	0250-5991:2003:Shaila M:severe:acute:respiratory
2	0223-5234:2006:Li Y:synthesis:of:stilbene
2	0196-9781:2004:Du Q:polyprotein:cleavage:mechanism
2	0196-6553:2006:Yuan J:a:climatologic:investigation
2	0196-6553:2006:Hsu C:confidence:in:controlling
2	0196-6553:2005:Wong T:handwashing:practice:and
2	0196-6553:2004:Lee N:infection:control:practices
2	0196-6553:2004:Jarvis W:the:state:of
2	0195-6701:2014:Goyal S:evaluating:the:virucidal
2	0195-6701:2005:Rabenau H:efficacy:of:various
2	0195-6701:2004:Tan Y:management:of:inpatients
2	0171-2004:2006:Schubert S:oligonucleotide:based:antiviral
2	0168-9525:2004:Grigoriev A:mutational:patterns:correlate
2	0168-6445:2006:Van Der Hoek L:human:coronavirus:nl
2	0168-1605:2010:Newell D:food:borne:diseases
2	0167-2789:2006:Small M:super:spreaders:and
2	0166-3542:2013:Hilgenfeld R:from:sars:to
2	0166-3542:2013:Cheng V:clinical:management:and
2	0166-3542:2012:Struck A:a:hexapeptide:of
2	0166-3542:2011:Zhou Y:inhibitors:of:sars
2	0166-3542:2010:Yang C:identification:of:phenanthroindolizines
2	0166-3542:2008:Canard B:international:research:networks
2	0166-3542:2008:Barnard D:is:the:anti
2	0166-3542:2007:Van Der Meer F:antiviral:activity:of
2	0166-3542:2007:Keyaerts E:plant:lectins:are
2	0166-3542:2007:Ho T:emodin:blocks:the
2	0166-3542:2007:Akerstrom S:inhibition:of:sars
2	0166-3542:2006:Tan Y:understanding:the:accessory
2	0166-3542:2006:Ho T:design:and:biological
2	0166-3542:2006:Haagmans B:coronaviruses:and:their
2	0166-3542:2006:Barnard D:enhancement:of:the
2	0166-3542:2006:Balzarini J:inhibition:of:feline
2	0166-3542:2005:Saijo M:inhibitory:effect:of
2	0166-3542:2005:Paragas J:interferon:alfacon:is
2	0166-3542:2005:Li S:identification:of:natural
2	0166-3542:2004:Gunther S:application:of:real
2	0166-0934:2008:Stevenson J:the:use:of
2	0166-0934:2008:Kammila S:a:rapid:point
2	0166-0934:2007:Qin Z:sirnas:targeting:terminal
2	0166-0934:2005:Wang X:study:on:the
2	0166-0934:2005:Wang X:concentration:and:detection
2	0166-0934:2005:Tripp R:monoclonal:antibodies:to
2	0166-0934:2005:Li Y:detection:of:the
2	0166-0934:2005:Lee Y:thermal:aggregation:of
2	0166-0934:2005:Ivens T:development:of:a
2	0166-0934:2004:Long W:a:universal:microarray
2	0166-0934:2004:Darnell M:inactivation:of:the
2	0166-0934:2004:Berry J:development:and:characterisation
2	0166-0934:2004:Adachi D:comprehensive:detection:and
2	0163-4453:2013:Chan K:cross:reactive:antibodies
2	0163-4453:2012:Chan J:is:the:discovery
2	0163-4453:2004:Cheng V:medical:treatment:of
2	0146-6615:2010:Buecher C:use:of:a
2	0146-6615:2009:Sung R:identification:of:viral
2	0146-6615:2009:Poh W:characterization:of:cytotoxic
2	0146-6615:2009:Dominguez S:detection:of:four
2	0146-6615:2007:Tang J:quantitative:temporal:spatial
2	0146-6615:2006:Okabayashi T:cytokine:regulation:in
2	0146-6615:2006:Fukushi S:evaluation:of:a
2	0146-6615:2005:Yang Y:autoantibodies:against:human
2	0146-6615:2005:Tsao K:false:positive:antibody
2	0146-6615:2005:Poon L:recurrent:mutations:associated
2	0146-6615:2005:Keightley M:real:time:nasba
2	0146-6615:2005:Huang K:an:interferon:related
2	0146-6615:2005:Huang J:rapid:and:sensitive
2	0146-6615:2005:Chmielewicz B:respiratory:disease:caused
2	0146-6615:2005:Chan P:evaluation:of:a
2	0146-6615:2005:Carattoli A:recombinant:protein:based
2	0146-6615:2004:Rawlinson W:new:point:of
2	0146-6615:2004:Huang L:evaluation:of:antibody
2	0146-6615:2004:Chan P:persistent:infection:of
2	0146-6615:2004:Chan P:evaluation:of:a
2	0146-6615:2003:Ng M:early:events:of
2	0143-6244:2008:Kelly D:pressure:transient:identification
2	0143-5221:2006:Chan P:sars:clinical:presentation
2	0143-5221:2005:Bustin S:real:time:reverse
2	0143-005X:2004:Lange J:use:of:disposable
2	0143-005X:2003:Leung G:the:impact:of
2	0143-005X:2003:Lee S:the:sars:epidemic
2	0143-005X:2003:Choi B:a:simple:approximate
2	0143-005X:2003:Chau P:monitoring:the:severe
2	0141-5492:2005:Lai C:expression:and:purification
2	0141-5492:2004:Tao S:one:tube:nested
2	0140-6736:2013:Breban R:interhuman:transmissibility:of
2	0140-6736:2004:Woo P:relative:rates:of
2	0140-6736:2004:Ter Meulen J:human:monoclonal:antibody
2	0140-6736:2003:Zhong N:epidemiology:and:cause
2	0140-6736:2003:Peiris J:coronavirus:as:a
2	0140-6736:2003:Peiris J:clinical:progression:and
2	0140-6736:2003:Nicholls J:lung:pathology:of
2	0140-6736:2003:Kuiken T:newly:discovered:coronavirus
2	0138-9130:2004:Chiu W:bibliometric:analysis:of
2	0125-2208:2007:Saenghirunvattana S:influenza:viral:infection
2	0125-1562:2004:Chantratita W:development:and:comparison
2	0112-1642:2004:So R:severe:acute:respiratory
2	0099-2240:2006:Sulaiman I:evaluation:of:affymetrix
2	0095-5108:2005:Jamieson D:emerging:infections:and
2	0095-1137:2006:Petrich A:multicenter:comparison:of
2	0095-1137:2006:Chen Y:epidemiological:and:genetic
2	0095-1137:2005:Woo P:differential:sensitivities:of
2	0095-1137:2005:Wang W:detection:of:severe
2	0095-1137:2005:Liu I:immunofluorescence:assay:for
2	0095-1137:2005:Inoue M:performance:of:single
2	0095-1137:2004:Woo P:false:positive:results
2	0095-1137:2004:Woo P:detection:of:specific
2	0095-1137:2004:Weidmann M:high:efficiency:detection
2	0095-1137:2004:Vinayagamoorthy T:identification:of:the
2	0095-1137:2004:Ng L:detection:of:severe
2	0095-1137:2004:Mahony J:performance:and:cost
2	0095-1137:2004:Lau S:detection:of:severe
2	0095-1137:2004:Hui R:reverse:transcriptase:pcr
2	0095-1137:2004:Hourfar M:comparison:of:two
2	0095-1137:2004:Gillim Ross L:discovery:of:novel
2	0095-1137:2004:Drosten C:evaluation:of:advanced
2	0095-1137:2004:Bressler A:preclinical:evaluation:of
2	0095-1137:2003:Yam W:evaluation:of:reverse
2	0090-3493:2003:Manocha S:severe:acute:respiratory
2	0070-217X:2005:Baric R:development:of:mouse
2	0066-4804:2014:Dyall J:repurposing:of:clinically
2	0066-4804:2014:De Wilde A:screening:of:an
2	0066-4804:2004:Wu C:inhibition:of:severe
2	0046-8177:2006:Ng W:the:comparative:pathology
2	0046-8177:2005:Shieh W:immunohistochemical:in:situ
2	0046-8177:2003:Franks T:lung:pathology:of
2	0043-1354:2009:Casanova L:survival:of:surrogate
2	0042-9686:2003:Pennington H:smallpox:and:bioterrorism
2	0041-1345:2004:Chui A:impact:of:severe
2	0041-1132:2006:Darnell M:evaluation:of:inactivation
2	0041-1132:2005:Lin L:inactivation:of:viruses
2	0041-1132:2004:Schmidt M:nat:screening:of
2	0036-5548:2007:Wang F:positive:rate:of
2	0036-5548:2004:Dahl H:in:vitro:inhibition
2	0031-3955:2005:Meissner H:reducing:the:impact
2	0028-4793:2003:Drosten C:identification:of:a
2	0028-0836:2005:Imai Y:angiotensin:converting:enzyme
2	0028-0836:2004:Yang Z:a:dna:vaccine
2	0028-0836:2003:Antia R:the:role:of
2	0025-729X:2003:Fisher D:preventing:local:transmission
2	0025-6196:2003:Sampathkumar P:sars:epidemiology:clinical
2	0023-6837:2004:Juang J:coupling:multiplex:rt
2	0022-538X:2012:Tanaka T:severe:acute:respiratory
2	0022-538X:2012:Schneider M:severe:acute:respiratory
2	0022-538X:2012:Rani M:increased:antibody:affinity
2	0022-538X:2012:Lokugamage K:severe:acute:respiratory
2	0022-538X:2012:Kawase M:simultaneous:treatment:of
2	0022-538X:2012:Huynh J:evidence:supporting:a
2	0022-538X:2012:Fukushi M:monitoring:of:s
2	0022-538X:2012:Frieman M:molecular:determinants:of
2	0022-538X:2012:Demogines A:evidence:for:ace
2	0022-538X:2012:Clay C:primary:severe:acute
2	0022-538X:2011:Bolles M:a:double:inactivated
2	0022-538X:2010:Zornetzer G:transcriptomic:analysis:reveals
2	0022-538X:2010:Plant E:achieving:a:golden
2	0022-538X:2010:Lau S:ecoepidemiology:and:complete
2	0022-538X:2010:Drexler J:genomic:characterization:of
2	0022-538X:2010:Donaldson E:metagenomic:analysis:of
2	0022-538X:2009:Yoshikawa N:differential:virological:and
2	0022-538X:2009:Rockx B:early:upregulation:of
2	0022-538X:2009:Madu I:characterization:of:a
2	0022-538X:2009:Khanolkar A:protective:and:pathologic
2	0022-538X:2009:Freundt E:molecular:determinants:for
2	0022-538X:2008:Siu Y:the:m:e
2	0022-538X:2008:Sheahan T:pathways:of:cross
2	0022-538X:2008:Rockx B:structural:basis:for
2	0022-538X:2008:Pacciarini F:persistent:replication:of
2	0022-538X:2008:Narayanan K:severe:acute:respiratory
2	0022-538X:2008:Baas T:genomic:analysis:reveals
2	0022-538X:2007:Wathelet M:severe:acute:respiratory
2	0022-538X:2007:Vlasova A:two:way:antigenic
2	0022-538X:2007:Vijaykrishna D:evolutionary:insights:into
2	0022-538X:2007:Versteeg G:the:coronavirus:spike
2	0022-538X:2007:Tan Y:induction:of:apoptosis
2	0022-538X:2007:Serrano P:nuclear:magnetic:resonance
2	0022-538X:2007:Schaecher S:the:orf:b
2	0022-538X:2007:Schaecher S:severe:acute:respiratory
2	0022-538X:2007:Rockx B:synthetic:reconstruction:of
2	0022-538X:2007:Oostra M:the:nucleotide:deletion
2	0022-538X:2007:Oostra M:localization:and:membrane
2	0022-538X:2007:Mcbride C:the:cytoplasmic:tail
2	0022-538X:2007:Law A:role:for:nonstructural
2	0022-538X:2007:Kopecky Bromberg S:severe:acute:respiratory
2	0022-538X:2007:Jung K:altered:pathogenesis:of
2	0022-538X:2007:Joseph J:crystal:structure:of
2	0022-538X:2007:Inoue Y:clathrin:dependent:entry
2	0022-538X:2007:Han D:specific:asparagine:linked
2	0022-538X:2007:Fukushi S:amino:acid:substitutions
2	0022-538X:2007:Frieman M:severe:acute:respiratory
2	0022-538X:2007:Eckerle L:high:fidelity:of
2	0022-538X:2007:Dong B:detection:of:a
2	0022-538X:2007:Corver J:gxxxg:motif:of
2	0022-538X:2006:Yen Y:modeling:the:early
2	0022-538X:2006:Snijder E:ultrastructure:and:origin
2	0022-538X:2006:Shih Y:identifying:epitopes:responsible
2	0022-538X:2006:Oostra M:glycosylation:of:the
2	0022-538X:2006:Leung D:extremely:low:exposure
2	0022-538X:2006:Lee J:mucosal:immunization:with
2	0022-538X:2006:Joseph J:crystal:structure:of
2	0022-538X:2006:Huang C:severe:acute:respiratory
2	0022-538X:2006:Egloff M:structural:and:functional
2	0022-538X:2006:De Albuquerque N:murine:hepatitis:virus
2	0022-538X:2006:Chan W:functional:characterization:of
2	0022-538X:2006:Chan C:modulation:of:the
2	0022-538X:2006:Broer R:important:role:for
2	0022-538X:2006:Almazan F:construction:of:a
2	0022-538X:2005:Yount B:severe:acute:respiratory
2	0022-538X:2005:Yi C:single:amino:acid
2	0022-538X:2005:Woo P:characterization:and:complete
2	0022-538X:2005:Van Den Brink E:molecular:and:biological
2	0022-538X:2005:Tseng C:apical:entry:and
2	0022-538X:2005:Tang B:comparative:host:gene
2	0022-538X:2005:Tan Y:the:severe:acute
2	0022-538X:2005:Surjit M:the:severe:acute
2	0022-538X:2005:Spiegel M:inhibition:of:beta
2	0022-538X:2005:Sims A:severe:acute:respiratory
2	0022-538X:2005:Sainz B:identification:and:characterization
2	0022-538X:2005:Rowland R:intracellular:localization:of
2	0022-538X:2005:Roberts A:severe:acute:respiratory
2	0022-538X:2005:Raman S:stem:loop:iv
2	0022-538X:2005:Poon L:identification:of:a
2	0022-538X:2005:Pewe L:a:severe:acute
2	0022-538X:2005:Peti W:structural:genomics:of
2	0022-538X:2005:Neuman B:inhibition:escape:and
2	0022-538X:2005:Mossel E:exogenous:ace:expression
2	0022-538X:2005:Lindner H:the:papain:like
2	0022-538X:2005:Kong W:modulation:of:the
2	0022-538X:2005:Keng C:amino:acids:to
2	0022-538X:2005:Hussain S:identification:of:novel
2	0022-538X:2005:Hsieh P:assembly:of:severe
2	0022-538X:2005:Guillen J:identification:of:the
2	0022-538X:2005:Graham R:the:nsp:replicase
2	0022-538X:2005:Cheung C:cytokine:responses:in
2	0022-538X:2005:Barretto N:the:papain:like
2	0022-538X:2005:Akerstrom S:nitric:oxide:inhibits
2	0022-538X:2004:Yang Z:ph:dependent:entry
2	0022-538X:2004:Weingartl H:immunization:with:modified
2	0022-538X:2004:Wang Y:t:cell:epitopes
2	0022-538X:2004:Tan Y:a:novel:severe
2	0022-538X:2004:Subbarao K:prior:infection:and
2	0022-538X:2004:Stavrinides J:mosaic:evolution:of
2	0022-538X:2004:St Jean J:human:respiratory:coronavirus
2	0022-538X:2004:Prentice E:identification:and:characterization
2	0022-538X:2004:Moore M:retroviruses:pseudotyped:with
2	0022-538X:2004:Ivanov K:multiple:enzymatic:activities
2	0022-538X:2004:Hogan R:resolution:of:primary
2	0022-538X:2004:Hofmann H:s:protein:of
2	0022-538X:2004:Harcourt B:identification:of:severe
2	0022-538X:2004:Giroglou T:retroviral:vectors:pseudotyped
2	0022-538X:2004:Fielding B:characterization:of:a
2	0022-538X:2004:Bhardwaj K:the:severe:acute
2	0022-538X:2004:Babcock G:amino:acids:to
2	0022-3417:2006:Lo A:how:the:sars
2	0022-3417:2004:To K:tissue:and:cellular
2	0022-3417:2004:To K:exploring:the:pathogenesis
2	0022-3417:2004:Hamming I:tissue:distribution:of
2	0022-2623:2009:Ghosh A:structure:based:design
2	0022-2623:2007:Wen C:specific:plant:terpenoids
2	0022-2623:2006:Zhang H:design:and:synthesis
2	0022-2623:2006:Yang S:synthesis:crystal:structure
2	0022-2623:2006:Tsai K:discovery:of:a
2	0022-2623:2006:Mcguigan C:application:of:phosphoramidate
2	0022-2623:2006:Lu I:structure:based:drug
2	0022-2623:2006:Kumar R:effect:of:various
2	0022-2623:2006:Di Santo R:novel:bifunctional:quinolonyl
2	0022-2623:2006:Biot C:design:and:synthesis
2	0022-2623:2005:Shie J:discovery:of:potent
2	0022-2623:2005:Kaeppler U:a:new:lead
2	0022-2623:2005:Hoever G:antiviral:activity:of
2	0022-2623:2005:Ghosh A:design:and:synthesis
2	0022-2623:2005:Fattorusso C:specific:targeting:highly
2	0022-2623:2004:Toney J:sabadinine:a:potential
2	0022-2623:2003:Ranise A:design:synthesis:sar
2	0022-2623:2000:Zouhiri F:structure:activity:relationships
2	0022-2623:1998:Artico M:geometrically:and:conformationally
2	0022-2623:1995:Kelly T:novel:non:nucleoside
2	0022-2615:2003:Hawkey P:severe:acute:respiratory
2	0022-1899:2010:Rockx B:escape:from:human
2	0022-1899:2010:Ching J:significance:of:the
2	0022-1899:2007:Darnell M:severe:acute:respiratory
2	0022-1899:2007:Chen C:open:reading:frame
2	0022-1899:2006:Tang J:the:large:nt
2	0022-1899:2006:Roberts A:therapy:with:a
2	0022-1899:2006:Poccia F:anti:severe:acute
2	0022-1899:2005:Lan Y:molecular:epidemiology:of
2	0022-1899:2005:Greenough T:development:and:characterization
2	0022-1899:2005:Farcas G:fatal:severe:acute
2	0022-1899:2005:Che X:antigenic:cross:reactivity
2	0022-1899:2004:Tong S:direct:sequencing:of
2	0022-1899:2004:Stroher U:severe:acute:respiratory
2	0022-1899:2004:Liu I:disease:specific:b
2	0022-1899:2004:Ho K:mild:illness:associated
2	0022-1317:2009:Siu K:severe:acute:respiratory
2	0022-1317:2009:Kuri T:interferon:priming:enables
2	0022-1317:2008:See R:severe:acute:respiratory
2	0022-1317:2008:Mathewson A:interaction:of:severe
2	0022-1317:2008:Lin H:identification:of:residues
2	0022-1317:2006:Spiegel M:interaction:of:severe
2	0022-1317:2006:See R:comparative:evaluation:of
2	0022-1317:2006:Chibo D:analysis:of:human
2	0022-1317:2005:Zakhartchouk A:severe:acute:respiratory
2	0022-1317:2005:You J:subcellular:localization:of
2	0022-1317:2005:Nal B:differential:maturation:and
2	0022-1317:2005:Law P:the:a:protein
2	0022-1317:2005:Jonassen C:molecular:identification:and
2	0022-1317:2005:Fukushi S:vesicular:stomatitis:virus
2	0022-1317:2005:Faber M:a:single:immunization
2	0022-1317:2004:Hertzig T:rapid:identification:of
2	0021-9746:2005:Wong S:development:of:a
2	0021-9746:2004:Tse G:pulmonary:pathological:features
2	0016-5085:2003:Leung W:enteric:involvement:of
2	0014-2972:2009:Oudit G:sars:coronavirus:modulation
2	0013-936x:2008:Peccia J:a:role:for
2	0013-936X:2007:Walker C:effect:of:ultraviolet
2	0012-3692:2006:Ho H:colonization:of:severe
2	0012-3692:2004:Liu C:clinical:and:laboratory
2	0009-9260:2004:Hong N:avascular:necrosis:of
2	0009-9147:2004:Poon L:rapid:detection:of
2	0009-9147:2004:Poon L:detection:of:sars
2	0009-9147:2004:Choy W:synthetic:peptide:studies

Manipulations en shell (Unix/Dilib)

HfdCat /Users/jacquesducloy/Documents/WicriRoot/Wicri/Sante/explor/Sras.storage/SrasV1/Data/Main/Merge/Idat.i.hfd| SxmlCut idx/l | grep ...

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021

	Serveur d'exploration SRAS - Merge (Accueil) Index « Idat.i » - tête de navigation
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration SRAS - Merge (Accueil)Index « Idat.i » - tête de navigation

Index : Idat.i

Les termes de plus forte occurence

Manipulations en shell (Unix/Dilib)

Serveur d'exploration SRAS - Merge (Accueil)

Index « Idat.i » - tête de navigation